297 related articles for article (PubMed ID: 26874365)
1. Analysis of Outcomes Using Low-Dose and Early Administration of Recombinant Activated Factor VII in Cardiac Surgery.
Brase J; Finger B; He J; Wirtz K; Stun L; McMillen R; Flynn B
Ann Thorac Surg; 2016 Jul; 102(1):35-40. PubMed ID: 26874365
[TBL] [Abstract][Full Text] [Related]
2. Use of recombinant activated factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgery.
Bowman LJ; Uber WE; Stroud MR; Christiansen LR; Lazarchick J; Crumbley AJ; Kratz JM; Toole JM; Crawford FA; Ikonomidis JS
Ann Thorac Surg; 2008 May; 85(5):1669-76; discussion 1676-7. PubMed ID: 18442563
[TBL] [Abstract][Full Text] [Related]
3. Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): a propensity score analysis.
Gelsomino S; Lorusso R; Romagnoli S; Bevilacqua S; De Cicco G; Billè G; Stefàno P; Gensini GF
Eur J Cardiothorac Surg; 2008 Jan; 33(1):64-71. PubMed ID: 17996457
[TBL] [Abstract][Full Text] [Related]
4. Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: clinical and economic outcomes.
Uber WE; Toole JM; Stroud MR; Haney JS; Lazarchick J; Crawford FA; Ikonomidis JS
J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1469-77.e2. PubMed ID: 21457998
[TBL] [Abstract][Full Text] [Related]
5. A Propensity-Score Matched Analysis on Outcomes Using Recombinant Activated Factor VII in Pediatric Cardiac Surgery.
Li Y; Zhao W; Luo Q; Wu X; Ding J; Yan F
J Cardiothorac Vasc Anesth; 2019 May; 33(5):1269-1275. PubMed ID: 30795967
[TBL] [Abstract][Full Text] [Related]
6. Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery.
Rao VK; Lobato RL; Bartlett B; Klanjac M; Mora-Mangano CT; Soran PD; Oakes DA; Hill CC; van der Starre PJ
J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1221-6. PubMed ID: 25281040
[TBL] [Abstract][Full Text] [Related]
7. Characteristics Associated With Mortality in 372 Patients Receiving Low-Dose Recombinant Factor VIIa (rFVIIa) for Cardiac Surgical Bleeding.
Baral P; Cotter E; Gao G; He J; Wirtz K; Sharma A; Zorn Iii T; Muehlebach G; Flynn B
J Cardiothorac Vasc Anesth; 2019 Aug; 33(8):2133-2140. PubMed ID: 30772178
[TBL] [Abstract][Full Text] [Related]
8. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
[TBL] [Abstract][Full Text] [Related]
9. Recombinant-activated factor VII in the paediatric cardiac surgery: single unit experience.
Agarwal V; Okonta KE; Lal PS
Afr J Paediatr Surg; 2012; 9(3):193-7. PubMed ID: 23250238
[TBL] [Abstract][Full Text] [Related]
10. Very low-dose recombinant Factor VIIa administration for cardiac surgical bleeding reduces red blood cell transfusions and renal risk: a matched cohort study.
Cotter E; Sharma A; Campton A; Gao G; He J; Wirtz K; Zorn T; Flynn BC
Blood Coagul Fibrinolysis; 2021 Oct; 32(7):473-479. PubMed ID: 34650021
[TBL] [Abstract][Full Text] [Related]
11. Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, efficacy, and safety outcomes.
Masud F; Bostan F; Chi E; Pass SE; Samir H; Stuebing K; Liebl MG
J Cardiothorac Vasc Anesth; 2009 Feb; 23(1):28-33. PubMed ID: 18948033
[TBL] [Abstract][Full Text] [Related]
12. A role for very low-dose recombinant activated factor VII in refractory bleeding after cardiac surgery: Lessons from an observational study.
Hoffmann T; Assmann A; Dierksen A; Roussel E; Ullrich S; Lichtenberg A; Albert A; Sixt S
J Thorac Cardiovasc Surg; 2018 Oct; 156(4):1564-1573.e8. PubMed ID: 29884487
[TBL] [Abstract][Full Text] [Related]
13. Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhage.
Feih JT; Juul JJ; G Rinka JR; Baumann Kreuziger LM; Pagel PS; Tawil JN
Ann Card Anaesth; 2019; 22(4):388-393. PubMed ID: 31621674
[TBL] [Abstract][Full Text] [Related]
14. Recombinant activated factor VII use in critically ill patients: clinical outcomes and thromboembolic events.
Brophy GM; Candeloro CL; Robles JR; Brophy DF
Ann Pharmacother; 2013 Apr; 47(4):447-54. PubMed ID: 23535812
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations.
Andersen ND; Bhattacharya SD; Williams JB; Fosbol EL; Lockhart EL; Patel MB; Gaca JG; Welsby IJ; Hughes GC
Ann Thorac Surg; 2012 Jun; 93(6):1921-8; discussion 1928-9. PubMed ID: 22551846
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative use of recombinant activated factor VII during complex aortic surgery.
Goksedef D; Panagopoulos G; Nassiri N; Levine RL; Hountis PG; Plestis KA
J Thorac Cardiovasc Surg; 2012 May; 143(5):1198-204. PubMed ID: 22285329
[TBL] [Abstract][Full Text] [Related]
17. Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery.
Chapman AJ; Blount AL; Davis AT; Hooker RL
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1314-8; discussion 1318-9. PubMed ID: 21601468
[TBL] [Abstract][Full Text] [Related]
18. Safety of recombinant factor VIIa in patients under extracorporeal membrane oxygenation.
Anselmi A; Guinet P; Ruggieri VG; Aymami M; Lelong B; Granry S; Malledant Y; Le Tulzo Y; Gueret P; Verhoye JP; Flecher E
Eur J Cardiothorac Surg; 2016 Jan; 49(1):78-84. PubMed ID: 25908783
[TBL] [Abstract][Full Text] [Related]
19. Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7).
Hacquard M; Durand M; Lecompte T; Boini S; Briançon S; Carteaux JP
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1320-7. PubMed ID: 21550261
[TBL] [Abstract][Full Text] [Related]
20. Impact of Early, Low-Dose Factor VIIa on Subsequent Transfusions and Length of Stay in Cardiac Surgery.
Sutherland L; Houchin A; Wang T; Wang S; Moitra V; Sharma A; Zorn T; Flynn BC
J Cardiothorac Vasc Anesth; 2022 Jan; 36(1):147-154. PubMed ID: 34103218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
